Category

0
18
Oral zinc for the prevention of hyperbilirubinaemia in neonates | Cochrane
In newborn infants less than one week old, does oral zinc salt supplementation compared to placebo or no treatment decrease the incidence of hyperbilirubinaemia (jaundice)?
cochrane.org
over 5 years ago

0
24
Interventions for dialysis patients with hepatitis C virus (HCV) infection | Cochrane
Hepatitis C is a disease of the liver caused by the hepatitis C virus (HCV) which spreads from person to person through blood contact which is a result of sharing drug needles, and other items contaminated with blood. This virus remains in the body for a long time and can affect the liver causing its slow destruction or cirrhosis and liver cancer. Infected people may have weakness, nausea, jaundice and lose weight. On blood tests they may have increase in liver enzymes and bilirubin.
cochrane.org
over 5 years ago